nodes	percent_of_prediction	percent_of_DWPC	metapath
Metocurine—CHRND—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00437	0.00437	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—MC4R—type 2 diabetes mellitus	0.00421	0.00421	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—GNB3—type 2 diabetes mellitus	0.00417	0.00417	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.00417	0.00417	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—ATP2A2—type 2 diabetes mellitus	0.0041	0.0041	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.00406	0.00406	CbGpPWpGaD
Metocurine—CHRM2—Regulation of Actin Cytoskeleton—SLC9A1—type 2 diabetes mellitus	0.004	0.004	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—GNB3—type 2 diabetes mellitus	0.00396	0.00396	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.00396	0.00396	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.00395	0.00395	CbGpPWpGaD
Metocurine—CHRNA1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.00391	0.00391	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.00378	0.00378	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—CALM1—type 2 diabetes mellitus	0.00375	0.00375	CbGpPWpGaD
Metocurine—CHRNA2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.00372	0.00372	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00371	0.00371	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.00361	0.00361	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.00354	0.00354	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00353	0.00353	CbGpPWpGaD
Metocurine—CHRND—Neuronal System—PRKCB—type 2 diabetes mellitus	0.00353	0.00353	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB3—type 2 diabetes mellitus	0.00344	0.00344	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Other—CCR5—type 2 diabetes mellitus	0.00342	0.00342	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—MTNR1B—type 2 diabetes mellitus	0.00328	0.00328	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.00326	0.00326	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—CALM1—type 2 diabetes mellitus	0.00319	0.00319	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—MTNR1B—type 2 diabetes mellitus	0.00304	0.00304	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—CALM1—type 2 diabetes mellitus	0.00303	0.00303	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.003	0.003	CbGpPWpGaD
Metocurine—CHRNA1—Neuronal System—PRKCB—type 2 diabetes mellitus	0.003	0.003	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	0.00295	0.00295	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—type 2 diabetes mellitus	0.00294	0.00294	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	0.00292	0.00292	CbGpPWpGaD
Metocurine—CHRNA2—Neuronal System—PRKCB—type 2 diabetes mellitus	0.00285	0.00285	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.00283	0.00283	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.00281	0.00281	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—GNB3—type 2 diabetes mellitus	0.00275	0.00275	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—AGTR2—type 2 diabetes mellitus	0.00275	0.00275	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.00275	0.00275	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.00265	0.00265	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.00265	0.00265	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.00264	0.00264	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.00261	0.00261	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.00261	0.00261	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	0.00255	0.00255	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.0025	0.0025	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—ADCY5—type 2 diabetes mellitus	0.00245	0.00245	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	0.00244	0.00244	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—ADRA2A—type 2 diabetes mellitus	0.00243	0.00243	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	0.00237	0.00237	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	0.00231	0.00231	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.00227	0.00227	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	0.00226	0.00226	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.00225	0.00225	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.00218	0.00218	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.00217	0.00217	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.00214	0.00214	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—CALM1—type 2 diabetes mellitus	0.0021	0.0021	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.00209	0.00209	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.00207	0.00207	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.00203	0.00203	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.00198	0.00198	CbGpPWpGaD
Metocurine—CHRM2—Calcium Regulation in the Cardiac Cell—PRKCB—type 2 diabetes mellitus	0.00198	0.00198	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.00198	0.00198	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.00194	0.00194	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.00193	0.00193	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.00193	0.00193	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.00192	0.00192	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—GNB3—type 2 diabetes mellitus	0.00191	0.00191	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.0019	0.0019	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.00184	0.00184	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.00171	0.00171	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—ADCY5—type 2 diabetes mellitus	0.0017	0.0017	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.0017	0.0017	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.0017	0.0017	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.00167	0.00167	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.00166	0.00166	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—CCR5—type 2 diabetes mellitus	0.0016	0.0016	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.00159	0.00159	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.00158	0.00158	CbGpPWpGaD
Metocurine—CHRM2—Regulation of Actin Cytoskeleton—PIK3R1—type 2 diabetes mellitus	0.00157	0.00157	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—C3—type 2 diabetes mellitus	0.00156	0.00156	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.00155	0.00155	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.00155	0.00155	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.00154	0.00154	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.00154	0.00154	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.0015	0.0015	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.0015	0.0015	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.00149	0.00149	CbGpPWpGaD
Metocurine—CHRM2—G alpha (i) signalling events—AGT—type 2 diabetes mellitus	0.00149	0.00149	CbGpPWpGaD
Metocurine—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	0.00149	0.00149	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.00147	0.00147	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.00147	0.00147	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.00145	0.00145	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.00145	0.00145	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.00142	0.00142	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.00141	0.00141	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.00136	0.00136	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.00134	0.00134	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.00129	0.00129	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.00127	0.00127	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.00127	0.00127	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.00124	0.00124	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.00123	0.00123	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.0012	0.0012	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.00118	0.00118	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.00116	0.00116	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.00115	0.00115	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.00115	0.00115	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.00114	0.00114	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.00112	0.00112	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.00111	0.00111	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.00109	0.00109	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.00109	0.00109	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.00108	0.00108	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.00108	0.00108	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.00102	0.00102	CbGpPWpGaD
Metocurine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—type 2 diabetes mellitus	0.00102	0.00102	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000993	0.000993	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000989	0.000989	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000977	0.000977	CbGpPWpGaD
Metocurine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000973	0.000973	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000969	0.000969	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000968	0.000968	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000947	0.000947	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000945	0.000945	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.00094	0.00094	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000935	0.000935	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.00091	0.00091	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.00091	0.00091	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.0009	0.0009	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.0009	0.0009	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000879	0.000879	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000874	0.000874	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000859	0.000859	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000854	0.000854	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.00085	0.00085	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000832	0.000832	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000832	0.000832	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000828	0.000828	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000818	0.000818	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000817	0.000817	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000801	0.000801	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000794	0.000794	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000772	0.000772	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000761	0.000761	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000758	0.000758	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000755	0.000755	CbGpPWpGaD
Metocurine—CHRM2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000755	0.000755	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000752	0.000752	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000745	0.000745	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000743	0.000743	CbGpPWpGaD
Metocurine—CHRM2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000741	0.000741	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000727	0.000727	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000708	0.000708	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000688	0.000688	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000681	0.000681	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000677	0.000677	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000658	0.000658	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000653	0.000653	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000644	0.000644	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000613	0.000613	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000607	0.000607	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000602	0.000602	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000602	0.000602	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000593	0.000593	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000586	0.000586	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000586	0.000586	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000585	0.000585	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000585	0.000585	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000582	0.000582	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000577	0.000577	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000556	0.000556	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000548	0.000548	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000535	0.000535	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000529	0.000529	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000523	0.000523	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000519	0.000519	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000516	0.000516	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000509	0.000509	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000507	0.000507	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000507	0.000507	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000504	0.000504	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000497	0.000497	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000486	0.000486	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000483	0.000483	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.00047	0.00047	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000469	0.000469	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000469	0.000469	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000462	0.000462	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000456	0.000456	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000454	0.000454	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000454	0.000454	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000446	0.000446	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000444	0.000444	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000444	0.000444	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000439	0.000439	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000427	0.000427	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000413	0.000413	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000412	0.000412	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000406	0.000406	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000406	0.000406	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.0004	0.0004	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000399	0.000399	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.00038	0.00038	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000374	0.000374	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000373	0.000373	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000354	0.000354	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.00035	0.00035	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000346	0.000346	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000346	0.000346	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000344	0.000344	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000343	0.000343	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000339	0.000339	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000334	0.000334	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000333	0.000333	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000329	0.000329	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000319	0.000319	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000312	0.000312	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000299	0.000299	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000294	0.000294	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	0.000287	0.000287	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000274	0.000274	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000273	0.000273	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000273	0.000273	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000268	0.000268	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000267	0.000267	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000267	0.000267	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000264	0.000264	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000252	0.000252	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000238	0.000238	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	0.000228	0.000228	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000225	0.000225	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000221	0.000221	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000221	0.000221	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.00022	0.00022	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.00021	0.00021	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.0002	0.0002	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.0002	0.0002	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000189	0.000189	CbGpPWpGaD
Metocurine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.000172	0.000172	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	0.00017	0.00017	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	0.000169	0.000169	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	0.000161	0.000161	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	0.000159	0.000159	CbGpPWpGaD
Metocurine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	0.000156	0.000156	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	0.000148	0.000148	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	0.000144	0.000144	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	0.000132	0.000132	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	0.00013	0.00013	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.98e-05	9.98e-05	CbGpPWpGaD
Metocurine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.21e-05	9.21e-05	CbGpPWpGaD
